PeptideStack
5.2kquestions
20kanswers
220users

If I reconstitute a 2 mg vial with 3 mL of sterile water for injection, what concentration do I end up with?

Asked 1 Jan 2025Modified 17 months agoViewed 13k times
19

Numbers first: 2 mg · 3 mL · sterile water for injection.

I can do the algebra. I am not confident about the conversion factors.

If there is a standard way to lay this out, I would rather learn that than invent one.

What is the general form of this calculation?

reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

330 questions
diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

308 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
shareeditfollowflag
BN
askedbridget_nyathi16k171 Jan 2025
The timing signature is the useful part. Everything else is confounded. – v_ramaswamy 3 months ago
add a comment

5 Answers

Accepted answer first, then by votes
77

Accepted answer

Add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.

The order of operations matters: temperature first, then diluent measurement, then injection, then gentle dissolution, then labeling.

On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.

Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

shareimprove this answerflag
KA
answered · acceptedkwn_analytical89k24821 Feb 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
86

Stated carefully, full dissolution of a well-lyophilised cake should take under a minute with gentle swirling and no agitation. If it takes ten minutes, the cake is either over-dried, partially collapsed, or the peptide has already aggregated.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.

Concretely, do not use the same needle to pierce the stopper and to administer.

The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

edited 23 Feb 2025 by deamidation_watch — clarified the distinction between purity and content

shareimprove this answerflag
DW
answereddeamidation_watch43k3829 Jan 2025
37

Read the cake before you touch the vial. An intact, opaque, evenly distributed puck that sits proud of the vial base is what a good lyophilisation cycle produces. Anything else — collapse, melt-back at the stopper, a glassy film, a cake that has slumped to one side — is evidence about the cycle, the shipping, or both.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.

Number of stopper piercings matters less than the gauge doing the piercing.

The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
SB
answereds_bhattacharya42k3810 Feb 2025
27

The relevant detail is that sodium chloride 0.9 per cent as a diluent is not a neutral substitution. Ionic strength affects peptide solubility and aggregation propensity.

A 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.

The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

shareimprove this answerflag
PM
answeredpieter_maas22k1815 Mar 2025
6Do you have a reference for the last claim? Not disputing it, just want to read it. – amara_nwachukwu 9 months ago
add a comment
-3

If the supplier documentation specifies a diluent, there is usually a reason, and if it specifies nothing, water for injection is the conservative default.

Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.

Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.

The caveat on all of this is that it assumes the vial contains what the label says.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

shareimprove this answerflag
DO
answeredDr_Lena_Ostrowska42k3818 Jan 2025
4This should probably be in the site help pages rather than buried in an answer. – rota_site 3 months ago
3Good answer, but the confidence interval in the cited trial is wider than implied. – per_haugen 2 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.